| Year |
Citation |
Score |
| 2023 |
Dolgalev I, Zhou H, Murrell N, Le H, Sakellaropoulos T, Coudray N, Zhu K, Vasudevaraja V, Yeaton A, Goparaju C, Li Y, Sulaiman I, Tsay JJ, Meyn P, Mohamed H, et al. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nature Communications. 14: 6764. PMID 37938580 DOI: 10.1038/s41467-023-42327-x |
0.535 |
|
| 2023 |
Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Dolgalev I, et al. Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 3912. PMID 37400453 DOI: 10.1038/s41467-023-39680-2 |
0.525 |
|
| 2023 |
Davalos V, Lovell CD, Von Itter R, Dolgalev I, Agrawal P, Baptiste G, Kahler DJ, Sokolova E, Moran S, Piqué L, Vega-Saenz de Miera E, Fontanals-Cirera B, Karz A, Tsirigos A, Yun C, et al. An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma. Nature Communications. 14: 1867. PMID 37015919 DOI: 10.1038/s41467-023-36967-2 |
0.531 |
|
| 2023 |
Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, Wang L, Lim HB, Oh G, Jing X, Beri N, Khanna L, Gonda T, Oberstein P, Hajdu C, ... ... Dolgalev I, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nature Communications. 14: 797. PMID 36781852 DOI: 10.1038/s41467-023-36296-4 |
0.572 |
|
| 2022 |
Maiti G, Monteiro de Barros MR, Hu N, Dolgalev I, Roshan M, Foster JW, Tsirigos A, Wahlin KJ, Chakravarti S. Single cell RNA-seq of human cornea organoids identifies cell fates of a developing immature cornea. Pnas Nexus. 1: pgac246. PMID 36712326 DOI: 10.1093/pnasnexus/pgac246 |
0.532 |
|
| 2022 |
Yeaton A, Cayanan G, Loghavi S, Dolgalev I, Leddin EM, Loo CE, Torabifard H, Nicolet D, Wang J, Corrigan K, Paraskevopoulou V, Starczynowski DT, Wang E, Abdel-Wahab O, Viny AD, et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discovery. PMID 35924979 DOI: 10.1158/2159-8290.CD-21-1146 |
0.633 |
|
| 2022 |
Zacharioudakis E, Agianian B, Kumar Mv V, Biris N, Garner TP, Rabinovich-Nikitin I, Ouchida AT, Margulets V, Nordstrøm LU, Riley JS, Dolgalev I, Chen Y, Wittig AJH, Pekson R, Mathew C, et al. Modulating mitofusins to control mitochondrial function and signaling. Nature Communications. 13: 3775. PMID 35798717 DOI: 10.1038/s41467-022-31324-1 |
0.452 |
|
| 2022 |
Moubarak RS, de Pablos-Aragoneses A, Ortiz-Barahona V, Gong Y, Gowen M, Dolgalev I, Shadaloey SAA, Argibay D, Karz A, Von Itter R, Vega-Sáenz de Miera EC, Sokolova E, Darvishian F, Tsirigos A, Osman I, et al. The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis. Science Advances. 8: eabi7127. PMID 35179962 DOI: 10.1126/sciadv.abi7127 |
0.541 |
|
| 2021 |
Akhmetzyanova I, Aaron T, Galbo P, Tikhonova A, Dolgalev I, Tanaka M, Aifantis I, Zheng D, Zang X, Fooksman D. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα. Blood Advances. 5: 3592-3608. PMID 34550328 DOI: 10.1182/bloodadvances.2021005327 |
0.521 |
|
| 2021 |
Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga LA, Zeck B, Lopez De Rodas Gregorio M, Dowling CM, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, et al. Targeting the Atf7ip-Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity. Cancer Immunology Research. PMID 34462284 DOI: 10.1158/2326-6066.CIR-21-0543 |
0.548 |
|
| 2021 |
Deng J, Thennavan A, Dolgalev I, Chen T, Li J, Marzio A, Poirier JT, Peng D, Bulatovic M, Mukhopadhyay S, Silver H, Papadopoulos E, Pyon V, Thakurdin C, Han H, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer. Nature Cancer. 2: 503-514. PMID 34142094 DOI: 10.1038/s43018-021-00208-6 |
0.465 |
|
| 2020 |
Ma C, Witkowski MT, Harris J, Dolgalev I, Sreeram S, Qian W, Tong J, Chen X, Aifantis I, Chen W. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche. Science Advances. 6. PMID 33127669 DOI: 10.1126/sciadv.aba5536 |
0.532 |
|
| 2020 |
Witkowski MT, Dolgalev I, Evensen NA, Ma C, Chambers T, Roberts KG, Sreeram S, Dai Y, Tikhonova AN, Lasry A, Qu C, Pei D, Cheng C, Robbins GA, Pierro J, et al. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. PMID 32470390 DOI: 10.1016/J.Ccell.2020.04.015 |
0.656 |
|
| 2020 |
Scortegagna M, Hockemeyer K, Dolgalev I, Poźniak J, Rambow F, Li Y, Feng Y, Tinoco R, Otero DC, Zhang T, Brown K, Bosenberg M, Bradley LM, Marine JC, Aifantis I, et al. Siah2 control of T-regulatory cells limits anti-tumor immunity. Nature Communications. 11: 99. PMID 31911617 DOI: 10.1038/S41467-019-13826-7 |
0.369 |
|
| 2019 |
Zhang S, Dolgalev I, Zhang T, Ran H, Levine DA, Neel BG. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nature Communications. 10: 5367. PMID 31772167 DOI: 10.1038/S41467-019-13116-2 |
0.356 |
|
| 2019 |
Schwartz CJ, Dolgalev I, Vasudevaraja V, Kelly S, Heguy A, Snuderl M, Cotzia P, Jour G, Darvishian F. Revisiting multifocal breast Cancer: a Clonality study of ductal carcinoma using whole exome sequencing. Human Pathology. PMID 31704365 DOI: 10.1016/J.Humpath.2019.08.021 |
0.32 |
|
| 2019 |
Floristán A, Morales L, Hanniford D, Martinez C, Castellano-Sanz E, Dolgalev I, Ulloa-Morales A, Vega-Saenz de Miera E, Moran U, Darvishian F, Osman I, Kirchhoff T, Hernando E. Functional analysis of RPS27 mutations and expression in melanoma. Pigment Cell & Melanoma Research. PMID 31663663 DOI: 10.1111/Pcmr.12841 |
0.371 |
|
| 2019 |
Guillamot M, Ouazia D, Dolgalev I, Yeung ST, Kourtis N, Dai Y, Corrigan K, Zea-Redondo L, Saraf A, Florens L, Washburn MP, Tikhonova AN, Malumbres M, Gong Y, Tsirigos A, et al. The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation. Nature Immunology. PMID 31406379 DOI: 10.1038/S41590-019-0454-6 |
0.65 |
|
| 2019 |
Tikhonova AN, Dolgalev I, Hu H, Sivaraj KK, Hoxha E, Cuesta-Domínguez Á, Pinho S, Akhmetzyanova I, Gao J, Witkowski M, Guillamot M, Gutkin MC, Zhang Y, Marier C, Diefenbach C, et al. Author Correction: The bone marrow microenvironment at single-cell resolution. Nature. PMID 31296938 DOI: 10.1038/S41586-019-1394-X |
0.633 |
|
| 2019 |
Hundeyin M, Kurz E, Mishra A, Kochen Rossi JA, Liudahl SM, Leis KR, Mehrotra H, Kim M, Torres LE, Ogunsakin A, Link J, Sears RC, Sivagnanam S, Goecks J, Islam KS, ... Dolgalev I, et al. Innate αβ T cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming. Cancer Discovery. PMID 31266770 DOI: 10.1158/2159-8290.Cd-19-0161 |
0.361 |
|
| 2019 |
Wang L, Yang H, Zamperone A, Diolaiti D, Palmbos PL, Abel EV, Purohit V, Dolgalev I, Rhim AD, Ljungman M, Hadju CH, Halbrook CJ, Bar-Sagi D, di Magliano MP, Crawford HC, et al. ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis. Genes & Development. PMID 31048544 DOI: 10.1101/Gad.323303.118 |
0.353 |
|
| 2019 |
Tikhonova AN, Dolgalev I, Hu H, Sivaraj KK, Hoxha E, Cuesta-Domínguez Á, Pinho S, Akhmetzyanova I, Gao J, Witkowski M, Guillamot M, Gutkin MC, Zhang Y, Marier C, Diefenbach C, et al. The bone marrow microenvironment at single-cell resolution. Nature. PMID 30971824 DOI: 10.1038/S41586-019-1104-8 |
0.662 |
|
| 2019 |
Tetz G, Vikina D, Brown S, Zappile P, Dolgalev I, Tsirigos A, Heguy A, Tetz V. Draft Genome Sequence of Streptococcus halitosis sp. nov., Isolated from the Dorsal Surface of the Tongue of a Patient with Halitosis. Microbiology Resource Announcements. 8. PMID 30701262 DOI: 10.1128/MRA.01704-18 |
0.453 |
|
| 2019 |
Deng J, Thennavan A, Pan Y, Dolgalev I, Chen T, Silver H, Harris M, Pyon V, Li F, Lee C, Tsirigos A, Rothenberg E, Perou CM, Wong K. Abstract 3223: Overcome LKB1 mutated cancer resistance to anti-PD1 treatment Cancer Research. 79: 3223-3223. DOI: 10.1158/1538-7445.Am2019-3223 |
0.575 |
|
| 2019 |
Witkowski M, Dolgalev I, Evensen N, Roberts K, Sreeram S, Dai Y, Tikhonova A, Loomis C, Mullighan C, Tsirigos A, Carroll W, Aifantis I. 2029 - THE RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IMMUNE MICROENVIRONMENT Experimental Hematology. 76: S49. DOI: 10.1016/J.Exphem.2019.06.301 |
0.674 |
|
| 2018 |
Adeegbe DO, Liu S, Hattersley M, Bowden M, Zhou CW, Li S, Vlahos R, Grondine M, Dolgalev I, Ivanova E, Quinn MM, Gao P, Hammerman PS, Bradner JE, Diehl JA, et al. BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer. Cancer Immunology Research. PMID 30087114 DOI: 10.1158/2326-6066.Cir-18-0077 |
0.577 |
|
| 2018 |
Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton SL, Zagzag D, Chiriboga L, Gardner SL, et al. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nature Communications. 9: 2868. PMID 30030436 DOI: 10.1038/S41467-018-05029-3 |
0.352 |
|
| 2018 |
Cui X, Morales RT, Qian W, Wang H, Gagner JP, Dolgalev I, Placantonakis D, Zagzag D, Cimmino L, Snuderl M, Lam RHW, Chen W. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. Biomaterials. 161: 164-178. PMID 29421553 DOI: 10.1016/J.Biomaterials.2018.01.053 |
0.341 |
|
| 2018 |
Sen R, Dolgalev I, Bayin NS, Heguy A, Tsirigos A, Placantonakis DG. Single-Cell RNA Sequencing of Glioblastoma Cells. Methods in Molecular Biology (Clifton, N.J.). 1741: 151-170. PMID 29392698 DOI: 10.1007/978-1-4939-7659-1_12 |
0.575 |
|
| 2018 |
Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, Dolgalev I, Clementi C, Tsirigos A, Erlebacher A. H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. The Journal of Clinical Investigation. 128: 233-247. PMID 29202469 DOI: 10.1172/Jci95937 |
0.53 |
|
| 2018 |
Romero R, Sayin VI, Shawn DM, Bauer M, Singh SX, LeBoeuf S, Karakousi TR, Ellis DC, Bhutkar A, Sanchez-Rivera F, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Dolgalev I, et al. Abstract A43: Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-A43 |
0.35 |
|
| 2017 |
Fanok MH, Sun A, Fogli LK, Narendran V, Eckstein M, Kannan K, Dolgalev I, Lazaris C, Heguy A, Laird ME, Sundrud MS, Liu C, Kutok J, Lacruz RS, Latkowski JA, et al. Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma. The Journal of Investigative Dermatology. PMID 29128259 DOI: 10.1016/J.Jid.2017.10.028 |
0.577 |
|
| 2017 |
Brown JA, Yonekubo Y, Hanson N, Sastre-Perona A, Basin A, Rytlewski JA, Dolgalev I, Meehan S, Tsirigos A, Beronja S, Schober M. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. Cell Stem Cell. 21: 650-664.e8. PMID 29100014 DOI: 10.1016/J.Stem.2017.10.001 |
0.586 |
|
| 2017 |
Tetz G, Vecherkovskaya M, Zappile P, Dolgalev I, Tsirigos A, Heguy A, Tetz V. Complete Genome Sequence of Kluyvera intestini sp. nov., Isolated from the Stomach of a Patient with Gastric Cancer. Genome Announcements. 5. PMID 29074664 DOI: 10.1128/Genomea.01184-17 |
0.51 |
|
| 2017 |
Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. 8: 64932-64953. PMID 29029402 DOI: 10.18632/Oncotarget.18117 |
0.582 |
|
| 2017 |
Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, Karakousi TR, Ellis DC, Bhutkar A, Sánchez-Rivera FJ, Subbaraj L, Martinez B, Bronson RT, Prigge JR, Schmidt EE, ... ... Dolgalev I, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nature Medicine. PMID 28967920 DOI: 10.1038/Nm.4407 |
0.353 |
|
| 2017 |
Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression. Cell. PMID 28823558 DOI: 10.1016/J.Cell.2017.07.032 |
0.675 |
|
| 2017 |
Cerrone M, Montnach J, Lin X, Zhao YT, Zhang M, Agullo-Pascual E, Leo-Macias A, Alvarado FJ, Dolgalev I, Karathanos TV, Malkani K, Van Opbergen CJM, van Bavel JJA, Yang HQ, Vasquez C, et al. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm. Nature Communications. 8: 106. PMID 28740174 DOI: 10.1038/S41467-017-00127-0 |
0.326 |
|
| 2017 |
Bayin NS, Frenster JD, Sen R, Si S, Modrek AS, Galifianakis N, Dolgalev I, Ortenzi V, Illa-Bochaca I, Khahera A, Serrano J, Chiriboga L, Zagzag D, Golfinos JG, Doyle W, et al. Notch signaling regulates metabolic heterogeneity in glioblastoma stem cells. Oncotarget. PMID 28586758 DOI: 10.18632/oncotarget.18117 |
0.54 |
|
| 2016 |
Strikoudis A, Lazaris C, Trimarchi T, Galvao Neto AL, Yang Y, Ntziachristos P, Rothbart S, Buckley S, Dolgalev I, Stadtfeld M, Strahl BD, Dynlacht BD, Tsirigos A, Aifantis I. Regulation of transcriptional elongation in pluripotency and cell differentiation by the PHD-finger protein Phf5a. Nature Cell Biology. PMID 27749823 DOI: 10.1038/Ncb3424 |
0.663 |
|
| 2016 |
Hanniford D, Martinez CN, Dolgalev I, Lattanzi MW, Vega-Saenz de Miera E, Robinson EM, Goldman C, Heguy A, Kirchhoff T, Osman I, Hernando E. Targeted next-generation sequencing of melanoma patient samples to reveal mutations in non-protein coding regions of targetable oncogenes. Journal of Clinical Oncology. 34: 9559-9559. DOI: 10.1200/Jco.2016.34.15_Suppl.9559 |
0.337 |
|
| 2016 |
Saliba J, Evensen NA, Meyer J, Dolgalev I, Newman D, Chowdhury A, Nersting J, Wang J, Schmiegelow K, Carroll WL. Using Whole Exome Sequencing in Pediatric Acute Lymphoblastic Leukemia Germline, Diagnosis, and Relapse Trios to Discover Novel Relapse Enriched Mutations for Clonal Backtracking By Ddpcr Blood. 128: 4085-4085. DOI: 10.1182/Blood.V128.22.4085.4085 |
0.368 |
|
| 2016 |
Frenster J, Bayin NS, Kane JR, Rubenstein J, Modrek A, Baitamal R, Dolgalev I, Rudzenski K, Snuderl M, Golfinos J, Doyle W, Pacione D, Chi A, Heguy A, Shohdy N, et al. STMC-25. GPR133 PROMOTES HYPOXIA-DRIVEN TUMOR PROGRESSION IN GLIOBLASTOMA Neuro-Oncology. 18: vi187-vi188. DOI: 10.1093/Neuonc/Now212.788 |
0.324 |
|
| 2015 |
Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, ... ... Dolgalev I, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discovery. PMID 26566875 DOI: 10.1182/Blood.V126.23.481.481 |
0.33 |
|
| 2015 |
Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Research. 75: 264-9. PMID 25488749 DOI: 10.1158/0008-5472.Can-14-1008 |
0.325 |
|
| 2015 |
Schatz JH, Horwitz SM, Teruya-Feldstein J, Lunning MA, Viale A, Huberman K, Socci ND, Lailler N, Heguy A, Dolgalev I, Migliacci JC, Pirun M, Palomba ML, Weinstock DM, Wendel HG. Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis. Leukemia. 29: 237-41. PMID 25257991 DOI: 10.1038/Leu.2014.261 |
0.322 |
|
| 2015 |
Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner SL, Allen JC, Wisoff JH, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister SM, et al. Abstract LB-172: Novel candidate oncogenic drivers in pineoblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-172 |
0.358 |
|
| 2015 |
Bayin NS, Sen R, Si S, Modrek AS, Ortenzi V, Zagzag D, Snuderl M, Golfinos JG, Doyle W, Galifianakis N, Chesler M, Illa-Bochaca I, Barcellos-Hoff MH, Dolgalev I, Heguy A, et al. STEM-04DEFINING GLIOBLASTOMA STEM CELL HETEROGENEITY Neuro-Oncology. 17: v208.4-v209. DOI: 10.1093/Neuonc/Nov234.04 |
0.383 |
|
| 2015 |
Karajannis M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. GENO-20NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: v95.4-v96. DOI: 10.1093/Neuonc/Nov215.20 |
0.347 |
|
| 2015 |
Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A, Zagzag D, Gardner S, Allen J, Wisoff J, Capper D, Hovestadt V, Ahsan S, Eberhart C, Pfister S, et al. MB-17 * NOVEL CANDIDATE ONCOGENIC DRIVERS IN PINEOBLASTOMA Neuro-Oncology. 17: iii23-iii23. DOI: 10.1093/Neuonc/Nov061.93 |
0.345 |
|
| 2014 |
Di Micco R, Fontanals-Cirera B, Low V, Ntziachristos P, Yuen SK, Lovell CD, Dolgalev I, Yonekubo Y, Zhang G, Rusinova E, Gerona-Navarro G, Cañamero M, Ohlmeyer M, Aifantis I, Zhou MM, et al. Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes. Cell Reports. 9: 234-47. PMID 25263550 DOI: 10.1016/J.Celrep.2014.08.055 |
0.665 |
|
| 2014 |
Paoluzzi L, Hanniford D, Sokolova E, Dolgalev I, Heguy A, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. Preclinical testing supports combined BET and BRAF inhibition as a promising therapeutic strategy for melanoma. Journal of Clinical Oncology. 32: 9072-9072. DOI: 10.1200/Jco.2014.32.15_Suppl.9072 |
0.306 |
|
| 2014 |
Sumru Bayin N, Si S, Modrek A, Song H, Zagzag D, Hoang DM, Wadghiri YZ, Dolgalev I, Baysan M, Heguy A, Barcellos-Hoff MH, Placantonakis D. SC-04 * NON-UNIFORM NOTCH SIGNALING UNDERLIES HETEROGENEITY WITHIN THE GLIOBLASTOMA STEM CELL POPULATION Neuro-Oncology. 16: v197-v197. DOI: 10.1093/Neuonc/Nou275.4 |
0.352 |
|
| 2013 |
Frattini V, Trifonov V, Chan JM, Castano A, Lia M, Abate F, Keir ST, Ji AX, Zoppoli P, Niola F, Danussi C, Dolgalev I, Porrati P, Pellegatta S, Heguy A, et al. The integrated landscape of driver genomic alterations in glioblastoma. Nature Genetics. 45: 1141-9. PMID 23917401 DOI: 10.1038/Ng.2734 |
0.359 |
|
| 2013 |
Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, et al. The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 45: 791-8. PMID 23685749 DOI: 10.1038/Ng.2643 |
0.356 |
|
| 2013 |
Schatz JH, Horwitz SM, Lunning MA, Dolgalev I, Huberman K, Heguy A, Viale A, Socci ND, Pirun M, Teruya-Feldstein J, Wendel H. Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified Blood. 122: 843-843. DOI: 10.1182/Blood.V122.21.843.843 |
0.399 |
|
| 2012 |
Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, She QB, Gallardo H, Liu C, Merghoub T, Hefter B, Dolgalev I, Viale A, Heguy A, De Stanchina E, Cobrinik D, et al. Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene. 31: 446-57. PMID 21725359 DOI: 10.1038/Onc.2011.250 |
0.39 |
|
| 2010 |
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 18: 11-22. PMID 20579941 DOI: 10.1016/J.Ccr.2010.05.026 |
0.313 |
|
| 2010 |
Xing F, Persaud Y, Pratilas C, Janakiraman M, She Q, Liu C, Dolgalev I, Heguy A, Wolchok J, Cobrinik D, Houghton A, Taylor B, Rosen N, Solit D. Abstract 1971: Concurrent loss of PTEN and RB is sufficient to confer BRAF independence in melanomas harboring V600E BRAF mutations Cancer Research. 70: 1971-1971. DOI: 10.1158/1538-7445.Am10-1971 |
0.362 |
|
| 2009 |
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 114: 144-7. PMID 19420352 DOI: 10.1182/Blood-2009-03-210039 |
0.326 |
|
| 2009 |
Xing F, Persaud Y, Pratilas C, Janakiraman M, She Q, Liu C, Dolgalev I, Heguy A, Wolchok J, Cobrinik D, Houghton A, Taylor B, Rosen N, Solit D. Abstract B87: Genomic complexity and BRAF/MEK‐dependence in V600E BRAF mutant melanoma Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B87 |
0.372 |
|
| 2007 |
Heguy A, Harvey BG, Leopold PL, Dolgalev I, Raman T, Crystal RG. Responses of the human airway epithelium transcriptome to in vivo injury Physiological Genomics. 29: 139-148. PMID 17164391 DOI: 10.1152/Physiolgenomics.00167.2006 |
0.306 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Patel JP, Abdel-Wahab O, Gonen M, Figueroa ME, Fernandez HF, Sun Z, Racevskis J, Van lierberghe P, Dolgalev I, Cheng J, Viale A, Socci N, Heguy A, Ketterling R, Gallagher RE, et al. High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial Blood. 116: 851-851. DOI: 10.1182/Blood.V116.21.851.851 |
0.297 |
|
| 2021 |
Fedele C, Li S, Teng KW, Foster CJR, Peng D, Ran H, Mita P, Geer MJ, Hattori T, Koide A, Wang Y, Tang KH, Leinwand J, Wang W, Diskin B, ... ... Dolgalev I, et al. SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. The Journal of Experimental Medicine. 218. PMID 33045063 DOI: 10.1084/jem.20201414 |
0.294 |
|
| 2010 |
Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, et al. Mutations in GNA11 in uveal melanoma. The New England Journal of Medicine. 363: 2191-9. PMID 21083380 DOI: 10.1056/Nejmoa1000584 |
0.293 |
|
| 2017 |
Fanok M, Sun A, Fogli L, Narendran V, Sause W, Kannan K, Dolgalev I, Heguy A, Fulmer Y, Sundrud M, Kutok J, Odum N, Goel S, Latkowski J, Torres V, et al. 149 Analysis of molecular etiology and bacterial triggers of cutaneous T cell lymphoma Journal of Investigative Dermatology. 137: S25. DOI: 10.1016/J.Jid.2017.02.163 |
0.292 |
|
| 2018 |
Schwartz CJ, Dolgalev I, Yoon E, Osman I, Heguy A, de Miera EV, Nimeh D, Jour G, Darvishian F. Microglandular Adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma. Human Pathology. PMID 30428388 DOI: 10.1016/J.Humpath.2018.10.021 |
0.282 |
|
| 2017 |
Koetz-Ploch L, Hanniford D, Dolgalev I, Sokolova E, Zhong J, Díaz-Martínez M, Bernstein E, Darvishian F, Flaherty KT, Chapman PB, Tawbi H, Hernando E. MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway. Pigment Cell & Melanoma Research. PMID 28140520 DOI: 10.1111/Pcmr.12578 |
0.281 |
|
| 2016 |
Weiss SA, Martinez CN, Vega-Saenz de Miera E, Dolgalev I, Shapiro RL, Heguy A, Hernando E, Kirchhoff T, Osman I. Genomic characterization of acral lentiginous melanoma: Identification of altered metabolism as a potential therapeutic target. Journal of Clinical Oncology. 34: 9524-9524. DOI: 10.1200/Jco.2016.34.15_Suppl.9524 |
0.281 |
|
| 2016 |
Bayin NS, Frenster JD, Kane JR, Rubenstein J, Modrek AS, Baitalmal R, Dolgalev I, Rudzenski K, Scarabottolo L, Crespi D, Redaelli L, Snuderl M, Golfinos JG, Doyle W, Pacione D, et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 5: e263. PMID 27775701 DOI: 10.1038/oncsis.2016.63 |
0.277 |
|
| 2015 |
Kranz TM, Harroch S, Manor O, Lichtenberg P, Friedlander Y, Seandel M, Harkavy-Friedman J, Walsh-Messinger J, Dolgalev I, Heguy A, Chao MV, Malaspina D. De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample. Schizophrenia Research. 166: 119-24. PMID 26091878 DOI: 10.1016/J.Schres.2015.05.042 |
0.275 |
|
| 2014 |
Blattner M, Lee DJ, O'Reilly C, Park K, MacDonald TY, Khani F, Turner KR, Chiu YL, Wild PJ, Dolgalev I, Heguy A, Sboner A, Ramazangolu S, Hieronymus H, Sawyers C, et al. SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (New York, N.Y.). 16: 14-20. PMID 24563616 DOI: 10.1593/Neo.131704 |
0.275 |
|
| 2015 |
Kranz TM, Goetz RR, Walsh-Messinger J, Goetz D, Antonius D, Dolgalev I, Heguy A, Seandel M, Malaspina D, Chao MV. Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk. Schizophrenia Research. PMID 26215504 DOI: 10.1016/J.Schres.2015.07.002 |
0.274 |
|
| 2015 |
Castells X, Karanović S, Ardin M, Tomić K, Xylinas E, Durand G, Villar S, Forey N, Le Calvez-Kelm F, Voegele C, Karlović K, Mišić M, Dittrich D, Dolgalev I, McKay JD, et al. Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26383547 DOI: 10.1158/1055-9965.Epi-15-0553 |
0.273 |
|
| 2023 |
Oh G, Wang A, Wang L, Li J, Werba G, Weissinger D, Zhao E, Dhara S, Hernandez RE, Ackermann A, Porcella S, Kalfakakou D, Dolgalev I, Kawaler EA, Golan T, et al. POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling. The Journal of Clinical Investigation. PMID 36976649 DOI: 10.1172/JCI165934 |
0.272 |
|
| 2012 |
Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. The New England Journal of Medicine. 366: 1079-89. PMID 22417203 DOI: 10.1056/Nejmoa1112304 |
0.272 |
|
| 2019 |
Elias HK, Shin JY, Ali MA, Chakraborty S, Ha CJ, Dolgalev I, Konishi C, Beerman I, Park CY. Identification of Old HSCs with Preserved Self-Renewal and Long-Term Reconstitution Potential Blood. 134: 2479-2479. DOI: 10.1182/Blood-2019-129508 |
0.27 |
|
| 2015 |
Schafer MJ, Dolgalev I, Alldred MJ, Heguy A, Ginsberg SD. Calorie Restriction Suppresses Age-Dependent Hippocampal Transcriptional Signatures. Plos One. 10: e0133923. PMID 26221964 DOI: 10.1371/Journal.Pone.0133923 |
0.266 |
|
| 2020 |
Zhang S, Iyer S, Ran H, Dolgalev I, Gu S, Wei W, Foster CJR, Loomis CA, Olvera N, Dao F, Levine DA, Weinberg RA, Neel BG. Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer. Cancer Discovery. PMID 33158842 DOI: 10.1158/2159-8290.CD-20-0455 |
0.264 |
|
| 2016 |
Culver BP, DeClercq J, Dolgalev I, Yu MS, Ma B, Heguy A, Tanese N. Huntington's Disease Protein Huntingtin Associates with its own mRNA. Journal of Huntington's Disease. PMID 26891106 DOI: 10.3233/Jhd-150177 |
0.262 |
|
| 2020 |
Bhattacharya A, Dubeykoskaya Z, Nguyen HT, Dolgalev I, Veeramachaneni R, Schmidt BL, Albertson DG. Abstract 6448: Oral cancer pain mediators released in exosomes are oncogenes with potential to shape the microenvironment and induce neuronal sensitivity Endocrinology. 80: 6448-6448. DOI: 10.1158/1538-7445.Am2020-6448 |
0.261 |
|
| 2020 |
Bhattacharya A, Janal MN, Veeramachaneni R, Dolgalev I, Dubeykovskaya Z, Tu NH, Kim H, Zhang S, Wu AK, Hagiwara M, Kerr AR, DeLacure MD, Schmidt BL, Albertson DG. Oncogenes overexpressed in metastatic oral cancers from patients with pain: potential pain mediators released in exosomes. Scientific Reports. 10: 14724. PMID 32895418 DOI: 10.1038/S41598-020-71298-Y |
0.253 |
|
| 2017 |
Dolgalev I, Sedlazeck F, Busby B. DangerTrack: A scoring system to detect difficult-to-assess regions. F1000research. 6: 443. PMID 28503299 DOI: 10.12688/F1000Research.11254.1 |
0.237 |
|
| 2019 |
Laino AS, Betts BC, Veerapathran A, Dolgalev I, Sarnaik A, Quayle SN, Jones SS, Weber JS, Woods DM. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics. Journal For Immunotherapy of Cancer. 7: 33. PMID 30728070 DOI: 10.1186/s40425-019-0517-0 |
0.234 |
|
| 2008 |
Ammous Z, Hackett NR, Butler MW, Raman T, Dolgalev I, O'Connor TP, Harvey BG, Crystal RG. Variability in small airway epithelial gene expression among normal smokers. Chest. 133: 1344-53. PMID 18339782 DOI: 10.1378/Chest.07-2245 |
0.229 |
|
| 2019 |
Snuderl M, Dolgalev I, Heguy A, Walsh MF, Benayed R, Jungbluth AA, Ladanyi M, Karajannis MA. Histone H3K36I mutation in a metastatic histiocytic tumor of the skull and response to sarcoma chemotherapy. Cold Spring Harbor Molecular Case Studies. 5. PMID 31645348 DOI: 10.1101/mcs.a004606 |
0.224 |
|
| 2021 |
Purohit V, Wang L, Yang H, Li J, Ney GM, Gumkowski ER, Vaidya AJ, Wang A, Bhardwaj A, Zhao E, Dolgalev I, Zamperone A, Abel EV, Magliano MPD, Crawford HC, et al. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes & Development. PMID 33446568 DOI: 10.1101/gad.344184.120 |
0.223 |
|
| 2014 |
Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Dolgalev I, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071 |
0.217 |
|
| 2023 |
Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, Li S, Sahu S, Liu Y, Ban Y, Guidry K, Hu H, Lopez A, Sherman F, Tan YJ, Lee YT, Armstrong AP, ... Dolgalev I, et al. Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy. Cancer Research. PMID 37729426 DOI: 10.1158/0008-5472.CAN-23-2729 |
0.216 |
|
| 2018 |
Snuderl M, Kannan K, Pfaff E, Wang S, Stafford J, Serrano J, Heguy A, Ray K, Faustin A, Aminova O, Dolgalev I, Stapleton S, Zagzag D, Chiriboga L, Gardner S, et al. EMBR-02. RECURRENT HOMOZYGOUS DELETION OF DROSHA AND MICRODUPLICATION OF PDE4DIP CONTAINING THE ANCESTRAL DUF1220 DOMAIN IN PINEOBLASTOMA Neuro-Oncology. 20: i69-i69. DOI: 10.1093/Neuonc/Noy059.187 |
0.208 |
|
| 2015 |
Durham BH, Diamond EL, Haroche J, Yao Z, Ma J, Parikh SA, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol J, Campbell P, Walsh MP, Sylvester B, ... Dolgalev I, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms Blood. 126: 481-481. DOI: 10.1182/blood.V126.23.481.481 |
0.207 |
|
| 2015 |
Jhawar S, Singh P, Torres D, Ramirez-Valle F, Kassem H, Banerjee T, Dolgalev I, Heguy A, Zavadil J, Lowenstein J. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease. Plos One. 10: e0118703. PMID 25811877 DOI: 10.1371/Journal.Pone.0118703 |
0.2 |
|
| 2019 |
Raman T, Dolgalev I, Errico TJ. 72. Operation timing affects outcomes after adult spinal deformity surgery The Spine Journal. 19: S35-S36. DOI: 10.1016/J.Spinee.2019.05.085 |
0.199 |
|
| 2019 |
Robello C, Maldonado DP, Hevia A, Hoashi M, Frattaroli P, Montacutti V, Heguy A, Dolgalev I, Mojica M, Iraola G, Dominguez-Bello MG. The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole. Plos One. 14: e0212593. PMID 30807605 DOI: 10.1371/Journal.Pone.0212593 |
0.196 |
|
| 2019 |
Robello C, Maldonado DP, Hevia A, Hoashi M, Frattaroli P, Montacutti V, Heguy A, Dolgalev I, Mojica M, Iraola G, Dominguez-Bello MG. Correction: The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole. Plos One. 14: e0215199. PMID 30947318 DOI: 10.1371/Journal.Pone.0215199 |
0.195 |
|
| 2021 |
Dolgalev I, Tikhonova AN. Connecting the Dots: Resolving the Bone Marrow Niche Heterogeneity. Frontiers in Cell and Developmental Biology. 9: 622519. PMID 33777933 DOI: 10.3389/fcell.2021.622519 |
0.187 |
|
| 2014 |
Judkins AR, Venneti S, Santi M, Felicella MM, Sullivan LM, Dolgalev I, Martinez D, Perry A, Lewis PW, Allis DC, Thompson CB. HISTOPATHOLOGIC EVALUATION OF H3K27ME3 IS A PROGNOSTIC BIOMARKER FOR PEDIATRIC GLIOBLASTOMAS Neuro-Oncology. 16: iii29-iii30. DOI: 10.1093/Neuonc/Nou208.26 |
0.18 |
|
| 2023 |
Wei W, Geer MJ, Guo X, Dolgalev I, Sanjana NE, Neel BG. Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition. The Journal of Experimental Medicine. 220. PMID 36820830 DOI: 10.1084/jem.20221563 |
0.169 |
|
| 2023 |
Mitra A, Thompson B, Strange A, Amato CM, Vassallo M, Dolgalev I, Hester-McCullough J, Muramatsu T, Kimono D, Puranik AS, Weber JS, Woods D. A Population of Tumor-Infiltrating CD4+ T-cells Co-expressing CD38 and CD39 is Associated with Checkpoint Inhibitor Resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37505479 DOI: 10.1158/1078-0432.CCR-23-0653 |
0.169 |
|
| 2023 |
Brabson JP, Leesang T, Yap YS, Wang J, Lam MQ, Fang B, Dolgalev I, Barbieri DA, Strippoli V, Bañuelos CP, Mohammad S, Lyon P, Chaudhry S, Donich D, Swirski A, et al. Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. Cell Reports. 42: 112027. PMID 36848231 DOI: 10.1016/j.celrep.2023.112027 |
0.165 |
|
| 2021 |
Larsen BM, Kannan M, Langer LF, Leibowitz BD, Bentaieb A, Cancino A, Dolgalev I, Drummond BE, Dry JR, Ho CS, Khullar G, Krantz BA, Mapes B, McKinnon KE, Metti J, et al. A pan-cancer organoid platform for precision medicine. Cell Reports. 36: 109429. PMID 34320344 DOI: 10.1016/j.celrep.2021.109429 |
0.165 |
|
| 2022 |
Cui X, Tan Morales RT, Qian W, Wang H, Gagner JP, Dolgalev I, Placantonakis D, Zagzag D, Cimmino L, Snuderl M, Lam RHW, Chen W. Corrigendum to "Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis" [Biomater. 161 (2018) 164-178]. Biomaterials. 287: 121667. PMID 35797856 DOI: 10.1016/j.biomaterials.2022.121667 |
0.143 |
|
| 2023 |
Castillo RL, Sidhu I, Dolgalev I, Chu T, Prystupa A, Subudhi I, Yan D, Konieczny P, Hsieh B, Haberman RH, Selvaraj S, Shiomi T, Medina R, Girija PV, Heguy A, et al. Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems. Science Immunology. 8: eabq7991. PMID 37267384 DOI: 10.1126/sciimmunol.abq7991 |
0.137 |
|
| 2021 |
Dinizo M, Dolgalev I, Passias PG, Errico TJ, Raman T. Complications After Adult Spinal Deformity Surgeries: All Are Not Created Equal. International Journal of Spine Surgery. 15: 137-143. PMID 33900967 DOI: 10.14444/8018 |
0.028 |
|
| 2022 |
Dinizo M, Patel K, Dolgalev I, Passias PG, Errico TJ, Raman T. Case Start Timing of Adult Spinal Deformity Surgeries: Does the Wait Matter? International Journal of Spine Surgery. 16: 20-26. PMID 35177531 DOI: 10.14444/8172 |
0.021 |
|
| 2019 |
Dolgalev IV, Brazovskaya NG, Ivanova AY, Shipkhineeva AY, Bogajchuk PM. [Impact of hypertension, overweight, hypertriglyceridemia and their combination for mortality rate according to the results of a 27-year cohort prospective study]. Kardiologiia. 59: 44-52. PMID 31884940 DOI: 10.18087/cardio.n344 |
0.02 |
|
| 2014 |
Dolgalev IV, Karpov RS. [Natural dynamics of blood pressure, body mass index and lipid levels in the elderly (the results of 17-year follow-up)]. Kardiologiia. 54: 16-20. PMID 25177781 DOI: 10.18565/cardio.2014.4.16-20 |
0.013 |
|
| 2017 |
Ivanova AY, Dolgalev IV. Impact of overweight and obesity on mortality (according to the results of a 27-year prospective study) Profilakticheskaya Meditsina. 20: 34. DOI: 10.17116/PROFMED201720334-39 |
0.01 |
|
| Hide low-probability matches. |